Found 0 matching trials
Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients PHASE2 At present, there is still controversy over the treatment of metastatic hor...
Show More Location
Shanghai General Hospital
Learn More & Join Trial
Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer PHASE2 This phase II trial tests how well pembrolizumab along with standard of car...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs. PHASE2 Although treatments for breast cancer have improved, 20-30% of patients wit...
Show More Location
Institut Bergonie
Learn More & Join Trial
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer PHASE3 This phase III trial compares the effect of giving triptorelin vs no tripto...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles PHASE2 The addition of heparin and prednisolone increases pregnancy outcome parame...
Show More Location
Assisted Reproduction Unit, 3rd Department of Obstetrics & Gynecology
Learn More & Join Trial
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer PHASE3 RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, ...
Show More Location
Clinique De Rochebelle
Learn More & Join Trial
Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles PHASE3 GnRH agonist administration in the luteal phase was reported to beneficiall...
Show More Location
American Hospital
Learn More & Join Trial
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response PHASE2 The objective of this study is to determine the safety and clinical effects...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer PHASE3 Assess the efficacy and safety of Triptorelin pamoate 3M formulation (11.25...
Show More Location
Multiple Locations
Learn More & Join Trial
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer PHASE3 RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, ...
Show More Location
The Kirklin Clinic at Acton Road
Learn More & Join Trial